Cibc Private Wealth Group, LLC Editas Medicine, Inc. Transaction History
Cibc Private Wealth Group, LLC
- $53.9 Billion
- Q3 2024
A detailed history of Cibc Private Wealth Group, LLC transactions in Editas Medicine, Inc. stock. As of the latest transaction made, Cibc Private Wealth Group, LLC holds 8,050 shares of EDIT stock, worth $19,400. This represents 0.0% of its overall portfolio holdings.
Number of Shares
8,050
Previous 8,150
1.23%
Holding current value
$19,400
Previous $38,000
28.95%
% of portfolio
0.0%
Previous 0.0%
Shares
8 transactions
Others Institutions Holding EDIT
# of Institutions
247Shares Held
57MCall Options Held
410KPut Options Held
394K-
Black Rock Inc. New York, NY7.78MShares$18.8 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.68MShares$16.1 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT4.9MShares$11.8 Million0.62% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny3.35MShares$8.08 Million0.01% of portfolio
-
State Street Corp Boston, MA2.46MShares$5.93 Million0.0% of portfolio
About Editas Medicine, Inc.
- Ticker EDIT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 68,737,200
- Market Cap $166M
- Description
- Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...